Table 5 Determinants of mortality

Gender

Male

1

–

–

Female

1.081 (0.874–1.336)

0.473

–

–

Age in years

10–14

1

–

–

15–19

1.167 (0.939–1.450)

0.163

–

–

Geographical setting

Urban

1

1

Rural

1.703 (1.268–2.286)

0.0001

6.521 (3.776–11.261)

0.0001

Level of Education

Primary

1

–

–

Secondary

1.039 (0.810–1.332)

0.765

–

–

Tertiary

1.190 (0.483–2.933)

0.705

–

–

None

1.121 (0.411–3.058)

0.823

–

–

Disclosure of HIV to study participants

Yes

1

–

–

No

1.280 (1.007–1.627)

0.044

–

–

Parental Status

Orphan

1.200 (0.963–1.495)

0.105

–

–

Non orphan

1

–

–

Baseline CD4 count

≥ 500 cell/mm³

1

–

–

< 500 cell/mm³

1.695 (1.230–2.337)

0.001

WHO clinical stage

Stage I/II

1

–

–

Stage III/IV

1.039 (0.801–1.349)

0.773

–

–

Retained in care

Yes

1

1

No

1.813 (0.962–3.418)

0.066

2.399 (1.156–4.979)

0.019

Anemia at start

Yes

1

1

–

No

0.373 (0.204–0.684)

0.001

0.207 (0.067–0.632)

0.006

Opportunistic infection

Yes

1.333 (0.961–1.850)

0.086

–

–

No

1

–

–

Treatment Regimen

First line

1.202 (0.815–1.771)

0.354

–

–

Second line

1

–

–

Cotrimoxazole prophylaxis

Yes

1

–

–

No

0.820 (0.536–1.254)

0.360

–

–

Exposure to NVP prophylaxis for PMTCT

Yes

1

–

–

No

1.845 (1.134–3.003)

0.014

–

–

Mode of Transmission

Vertical

1

–

–

Horizontal

2.575 (1.464–4.530)

0.001

–

–